An Increase in Natural Killer Cells Linked to Severe Cases of RSV in Children
Researchers analyzed airway and blood samples from children with respiratory syncytial virus (RSV). They discovered elevated ...
NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)
Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer cell ...
AZoRobotics on MSN1d
AI Revolutionizes Cell Analysis in Cancer Therapy
The TIMING™ platform, supported by AI, enables advanced label-free cell analysis for cancer immunotherapy. By observing ...
Parade on MSN4d
The Genius Immune System Trick We Wish We'd Known About Sooner
The CDC recommends most adults log at least seven hours of sleep per night, putting emotional well-being at the top of the ...
Medscape5d
Roles and Mechanism of Natural Killer Cells in Clinical and Experimental Transplantation
ILT: Immunoglobulin-like transcript; KIR: Killer cell immunoglobulin-like receptor; LIR: Leukocyte immunoglobulin-like receptor; MIC: MHC class I-like; NKR: Natural killer cell receptor ...
cidrap.umn4d
Study: Natural killer cells determine RSV severity
Researchers from Brigham and Women’s Hospital published new research in Science Translational Medicine showing that natural ...
Phio Pharmaceuticals Presenting Data on Its INSTAYL Compound PH-894 at ASGCT's 2024 Advancing Gene and Cell Therapies for Cancer Conference
PH-894: Potent and Specific Silencing of BRD4 in NK CellsMarlborough, Massachusetts--( - October 16, 2024) - Phio ...
Daily3d
Medical Bulletin 15/ October/ 2024 - Video
Here are the top medical news for the day:1 in 4 Adults Suspect They Have Undiagnosed ADHDA new national survey of 1,000 ...
Celularity Expands Advanced Biomaterial Product Commercial Portfolio with Acquisition of Rebound™ Product from Sequence LifeScience, Inc.
Celularity Inc. (Nasdaq: CELU) (“Celularity”), a regenerative and cellular medicine company, today announced that it had added to its commercial portfolio of placental-derived advanced biomaterial ...
Stockhead on MSN5d
Health Check: Thirsty Chimeric goes to the well for funding top-up
Cancer drug developer gets much-needed funds, plus Clarity launches cancer diagnosis trial and LTR delivers ED spray trial ...
GMP Cell Therapy Consumables Market Projected To Witness Substantial Growth, 2024-2031: GE Healthcare, Takara Bio Inc.
GMP Cell Therapy Consumables market is expected to reach USD 80.03 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 28.2% from 2024 to 2031.